HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al‐Saud Institute for Computational Biomedicine

The Institute for Computational Biomedicine (ICB) uses applied mathematics and computer-based technologies to enhance the study of medicine and tackle the most challenging questions in systems biology. Faculty members collaborate with clinicians from the Caryl and Israel Englander Institute for Precision Medicine and other departments, and they conduct research in computational neuroscience, computational cancer genomics and statistical genetics, among other topics. The institute trains the next generation of computational biologists, as well as scientists with a strong background in computer science and mathematics.  ICB faculty teach in graduate programs including the Tri-Institutional Training Program in Computational Biology and Medicine, the neuroscience Ph.D. program and the Tri-Institutional Ph.D. Program in Chemical Biology.


Weill Cornell Medicine Faculty Named AAAS Fellows

January 31, 2023

Two Weill Cornell Medicine faculty members, Dr. David Lyden and Dr. Harel Weinstein have been elected fellows of the American Association for the Advancement of Science (AAAS).
New Collaborations Win Funding from Starr Cancer Consortium

March 10, 2022

Two multi-institutional teams led by Weill Cornell Medicine scientists have been awarded grant support from the Starr Cancer Consortium. Both grants will fund work applying new...
Researchers Identify Significant Differences in Tumor Characteristics Between Younger and Older Cancer Patients

December 7, 2021

Investigators at Weill Cornell Medicine have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several...